A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class

por Hoffman, Keith B., Kraus, Christina, Dimbil, Mo, Golomb, Beatrice A.
Publicado 2012

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

por Hoffman, Keith B., Dimbil, Mo, Erdman, Colin B., Tatonetti, Nicholas P., Overstreet, Brian M.
Publicado 2014

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)

por Hoffman, Keith B., Demakas, Andrea R., Dimbil, Mo, Tatonetti, Nicholas P., Erdman, Colin B.
Publicado 2014

Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

por Hoffman, Keith B., Dimbil, Mo, Erdman, Colin B., Tatonetti, Nicholas P., Overstreet, Brian M.
Publicado 2014

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System

por Duprey, Matthew S., Al-Qadheeb, Nada S., O’Donnell, Nick, Hoffman, Keith B., Weinstock, Jonathan, Madias, Christopher, Dimbil, Mo, Devlin, John W.
Publicado 2019

A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes

por Hoffman, Keith B., Dimbil, Mo, Kyle, Robert F., Tatonetti, Nicholas P., Erdman, Colin B., Demakas, Andrea, Chen, Dingguo, Overstreet, Brian M.
Publicado 2015